How High Will Brown Forman Stock Go?
On the surface, Brown‑Forman (NYSE: BF.B) is having an unremarkable year.…
Sell
32
GLBZ Quote, Financials, Valuation and Earnings
Last price:
$5.32
Seasonality move
:
-0.63%
Day range:
$5.37 - $5.37
52-week range:
$4.02 - $6.99
Dividend yield:
7.45%
P/E ratio:
537.04x
P/S ratio:
1.33x
P/B ratio:
0.81x
Volume:
782
Avg. volume:
13.1K
1-year change:
20.68%
Market cap:
$15.6M
Revenue:
$11.8M
EPS (TTM):
$0.01
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.8M | $12.7M | $13M | $12.9M | $11.8M | |
| Revenue Growth (YoY) | -5.08% | -0.63% | 1.88% | -0.37% | -8.81% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.4M | $7.2M | $7M | $7.4M | $7.3M | |
| Other Inc / (Exp) | $6K | -$588K | $208K | -- | -- | |
| Operating Expenses | $7.4M | $7.2M | $7M | $7.4M | $7.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.2M | $3.1M | $2M | $1.5M | -$637K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $491K | $577K | $240K | $72K | -$525K | |
| Net Income to Company | $1.7M | $2.5M | $1.7M | $1.4M | -$112K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.7M | $2.5M | $1.7M | $1.4M | -$112K | |
| Basic EPS (Cont. Ops) | $0.59 | $0.88 | $0.61 | $0.50 | -$0.04 | |
| Diluted EPS (Cont. Ops) | $0.59 | $0.88 | $0.61 | $0.50 | -$0.04 | |
| Weighted Average Basic Share | $2.8M | $2.8M | $2.9M | $2.9M | $2.9M | |
| Weighted Average Diluted Share | $2.8M | $2.8M | $2.9M | $2.9M | $2.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.7M | $4.2M | $2.8M | $2.7M | $3.6M | |
| Revenue (Reported) | $12.8M | $12.7M | $13M | $12.9M | $11.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.7M | $4.2M | $2.8M | $2.7M | $3.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1M | $3M | $3.4M | $2.8M | $2.7M | |
| Revenue Growth (YoY) | -3.65% | -3.43% | 13.65% | -18.29% | -2.61% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.8M | $1.7M | $1.8M | $1.7M | $1.9M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.8M | $1.7M | $1.8M | $1.7M | $1.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $700K | $252K | $521K | -$229K | $124K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $106K | $21K | $86K | -$232K | -$29K | |
| Net Income to Company | $594K | $231K | $435K | $3K | $153K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $594K | $231K | $435K | $3K | $153K | |
| Basic EPS (Cont. Ops) | $0.21 | $0.08 | $0.15 | -- | $0.05 | |
| Diluted EPS (Cont. Ops) | $0.21 | $0.08 | $0.15 | -- | $0.05 | |
| Weighted Average Basic Share | $2.8M | $2.9M | $2.9M | $2.9M | $2.9M | |
| Weighted Average Diluted Share | $2.8M | $2.9M | $2.9M | $2.9M | $2.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $984K | $486K | $628K | $604K | $1.2M | |
| Revenue (Reported) | $3.1M | $3M | $3.4M | $2.8M | $2.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $984K | $486K | $628K | $604K | $1.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.7M | $12.6M | $13.4M | $12.3M | $11.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.4M | $7.1M | $7.1M | $7.3M | $7.5M | |
| Other Inc / (Exp) | $6K | -$588K | $208K | -- | -- | |
| Operating Expenses | $7.4M | $7.1M | $7.1M | $7.3M | $7.5M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.5M | $2.6M | $2.3M | $750K | -$285K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $522K | $492K | $305K | -$247K | -$323K | |
| Net Income to Company | $2M | $2.2M | $1.9M | $997K | $38K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2M | $2.2M | $1.9M | $997K | $38K | |
| Basic EPS (Cont. Ops) | $0.70 | $0.75 | $0.68 | $0.35 | $0.01 | |
| Diluted EPS (Cont. Ops) | $0.70 | $0.75 | $0.68 | $0.35 | $0.01 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.9M | $3.7M | $3M | $2.7M | $4.2M | |
| Revenue (Reported) | $12.7M | $12.6M | $13.4M | $12.3M | $11.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.9M | $3.7M | $3M | $2.7M | $4.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1M | $3M | $3.4M | $2.8M | $2.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.8M | $1.7M | $1.8M | $1.7M | $1.9M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.8M | $1.7M | $1.8M | $1.7M | $1.9M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $700K | $252K | $521K | -$229K | $124K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $106K | $21K | $86K | -$232K | -$29K | |
| Net Income to Company | $594K | $231K | $435K | $3K | $153K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $594K | $231K | $435K | $3K | $153K | |
| Basic EPS (Cont. Ops) | $0.21 | $0.08 | $0.15 | -- | $0.05 | |
| Diluted EPS (Cont. Ops) | $0.21 | $0.08 | $0.15 | -- | $0.05 | |
| Weighted Average Basic Share | $2.8M | $2.9M | $2.9M | $2.9M | $2.9M | |
| Weighted Average Diluted Share | $2.8M | $2.9M | $2.9M | $2.9M | $2.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $984K | $486K | $628K | $604K | $1.2M | |
| Revenue (Reported) | $3.1M | $3M | $3.4M | $2.8M | $2.7M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $984K | $486K | $628K | $604K | $1.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $37.1M | $62.2M | $30.1M | $15.2M | $24.5M | |
| Short Term Investments | $114M | $155.9M | $144.1M | $126.2M | $74.5M | |
| Accounts Receivable, Net | $1.3M | $1.1M | $1.2M | $1.2M | $1.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $318K | $347K | $493K | $475K | $471K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $152.9M | $219.8M | $175.9M | $143.3M | $101M | |
| Property Plant And Equipment | $3.9M | $3.6M | $3.3M | $3M | $2.7M | |
| Long-Term Investments | $114M | $155.9M | $144.1M | $126.2M | $74.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $419.5M | $442.1M | $381.4M | $351.8M | $359M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $29.9M | $10M | -- | $30M | $30M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $29.9M | $10M | $151K | $30M | $30M | |
| Long-Term Debt | -- | $10M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $382.4M | $406.4M | $365.4M | $332.5M | $341.1M | |
| Common Stock | $2.8M | $2.9M | $2.9M | $2.9M | $2.9M | |
| Other Common Equity Adj | $540K | -$874K | -$21.3M | -$18.4M | -$19M | |
| Common Equity | $37.1M | $35.7M | $16.1M | $19.3M | $17.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $37.1M | $35.7M | $16.1M | $19.3M | $17.8M | |
| Total Liabilities and Equity | $419.5M | $442.1M | $381.4M | $351.8M | $359M | |
| Cash and Short Terms | $151.1M | $218.1M | $174.2M | $141.5M | $99M | |
| Total Debt | $29.9M | $20M | -- | $30M | $30M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $40.5M | $68.8M | $14.6M | $42.6M | $23.7M | |
| Short Term Investments | $134.9M | $147.4M | $144.7M | $128.7M | $106.6M | |
| Accounts Receivable, Net | $1.3M | $1.1M | $1.3M | $1.3M | $1.2M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $410K | $513K | $479K | $460K | $474K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $177.1M | $218.1M | $161.1M | $173.5M | $132.2M | |
| Property Plant And Equipment | $3.8M | $3.5M | $3.2M | $2.9M | $2.6M | |
| Long-Term Investments | $134.9M | $147.4M | $144.7M | $128.7M | $106.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $436.7M | $437.4M | $363.4M | $369.9M | $358M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $31.2M | $10M | -- | $40M | $20M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $31.2M | $10M | -- | $40M | $20M | |
| Long-Term Debt | -- | $10M | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $403.2M | $410.2M | $345.2M | $351.7M | $338.8M | |
| Common Stock | $2.8M | $2.9M | $2.9M | $2.9M | $2.9M | |
| Other Common Equity Adj | -$1.9M | -$9.3M | -$19.2M | -$19.3M | -$17.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $33.5M | $27.3M | $18.2M | $18.1M | $19.2M | |
| Total Liabilities and Equity | $436.7M | $437.4M | $363.4M | $369.9M | $358M | |
| Cash and Short Terms | $175.4M | $216.2M | $159.3M | $171.4M | $130.3M | |
| Total Debt | $31.2M | $20M | -- | $40M | $20M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7M | $2.5M | $1.7M | $1.4M | -$112K | |
| Depreciation & Amoritzation | $59K | $995K | $994K | $227K | $238K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | $217K | -$73K | -$33K | -$154K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6M | $3.7M | $2.2M | $1.4M | $28K | |
| Capital Expenditures | $573K | $287K | $256K | $152K | $81K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$9.9M | -$1.3M | $7M | $17.7M | $847K | |
| Dividends Paid (Ex Special Dividend) | -$1.1M | -$1.1M | -$1.1M | -$1.1M | -$865K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.9M | $10M | -- | $30M | -- | |
| Long-Term Debt Repaid | -- | -$19.9M | -$10M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $130K | $131K | $114K | $120K | $91K | |
| Cash From Financing | $32.1M | $22.7M | -$41.3M | -$33.9M | $8.3M | |
| Beginning Cash (CF) | $13.3M | $37.1M | $62.2M | $30.1M | $15.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $23.8M | $25.1M | -$32.1M | -$14.9M | $9.2M | |
| Ending Cash (CF) | $37.1M | $62.2M | $30.1M | $15.2M | $24.5M | |
| Levered Free Cash Flow | $1M | $3.4M | $2M | $1.2M | -$53K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $480K | $309K | $275K | -$204K | -- | |
| Depreciation & Amoritzation | $109K | $108K | $113K | $46K | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$27K | -$21K | $121K | -$78K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.3M | $764K | $621K | $140K | -- | |
| Capital Expenditures | $77K | $105K | $232K | $113K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.7M | -$16M | -$4.4M | -$12.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -$285K | -$285K | -$286K | -$290K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$1.3M | -- | $15M | -- | -- | |
| Long-Term Debt Repaid | -$4.7M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $33K | $29K | $30K | $32K | -- | |
| Cash From Financing | -$6.3M | -$2.3M | $954K | -$13.6M | -- | |
| Beginning Cash (CF) | $40.5M | $68.8M | $14.6M | $42.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$13.7M | -$17.5M | -$2.8M | -$25.8M | -- | |
| Ending Cash (CF) | $26.8M | $51.4M | $11.7M | $16.8M | -- | |
| Levered Free Cash Flow | $1.2M | $659K | $389K | $27K | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2M | $2.2M | $1.9M | $997K | $38K | |
| Depreciation & Amoritzation | $63K | $998K | $990K | $228K | -$113K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $33K | $153K | -$135K | -$21K | $37K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2M | $3.1M | $2.7M | $1.3M | -$502K | |
| Capital Expenditures | $379K | $246K | $252K | $143K | $47K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$37M | $18.6M | $8.9M | $21.6M | -$6M | |
| Dividends Paid (Ex Special Dividend) | -$1.1M | -$1.1M | -$1.1M | -$1.1M | -$578K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $40M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $132K | $125K | $117K | $119K | -- | |
| Cash From Financing | $57.4M | $6.6M | -$65.8M | $5.2M | -$12.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $22.4M | $28.4M | -$54.2M | $28M | -$19M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.7M | $2.9M | $2.4M | $1.1M | -$502K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1M | $540K | $710K | -$201K | $153K | |
| Depreciation & Amoritzation | $213K | $215K | $216K | $150K | -$247K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2K | -$60K | $20K | -$167K | $102K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.5M | $534K | $851K | $259K | -$411K | |
| Capital Expenditures | $165K | $152K | $275K | $147K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$25.9M | -$13.4M | $41K | -$4M | $1.6M | |
| Dividends Paid (Ex Special Dividend) | -$569K | -$571K | -$573K | -$577K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $15M | -- | -- | |
| Long-Term Debt Repaid | -$4.7M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $66K | $56K | $60K | $61K | -- | |
| Cash From Financing | $14.1M | $2M | -$19.2M | $5.3M | -$1.9M | |
| Beginning Cash (CF) | $77.6M | $131M | $44.7M | $57.9M | $24.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.3M | -$10.8M | -$18.3M | $1.5M | -$788K | |
| Ending Cash (CF) | $67.2M | $120.2M | $26.3M | $59.4M | $23.7M | |
| Levered Free Cash Flow | $1.4M | $382K | $576K | $112K | -$411K | |
Get GLBZ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GLBZ
Sector
P/E ratio
537.04x
12.21x
PEG ratio
--
0.40x
P/B ratio
0.81x
1.10x
Price / LTM sales
1.33x
2.66x
Growth Metrics
GLBZ
Sector
Revenue growth
-2.61%
5.02%
Earnings growth
4707.69%
2.75%
Revenue (5-year growth)
-2.68%
5.15%
Earnings forecast
--
$0.61
Profitability
GLBZ
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
0.08%
5.2%
Return on assets
0.01%
0.97%
Return on equity
0.2%
9.24%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Aug
6
Balance Sheet
GLBZ
Sector
Total cash
$130.3M
$451.2M
Short term investments
$74.5M
$220.9M
Total assets
$359M
$3.8B
Long term debt
$20M
$285.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
